The invention belongs to the technical field of
vaccine research and development, and particularly relates to a method for testing the
efficacy of a porcine
pseudorabies GE
gene deletion
inactivated vaccine, which comprises the following steps of: inoculating a porcine
pseudorabies virus HNQYY2012gE strain
virus seed (the
virus content per 1ml is more than or equal to 108.5 TCID50) into suspension cultured ST cells according to MOI = 0.05, sampling every 12 hours after
virus inoculation, counting and observing the
cytopathic effect, and determining the
efficacy of the
inactivated vaccine with the
efficacy of the porcine
pseudorabies GE
gene deletion
inactivated vaccine according to the efficacy of the inactivated vaccine with the efficacy of the porcine pseudorabies GE
gene deletion inactivated vaccine and the efficacy of the porcine pseudorabies GE
gene deletion inactivated vaccine. The method comprises the following steps of: simultaneously measuring the
titer of TCID50, sampling, counting and observing the cytopathy condition 42 hours after
virus inoculation, simultaneously immunizing and replacing an animal
guinea pig and a target animal pig by using a porcine pseudorabies inactivated vaccine (HNQYY2012gE strain), and researching the correlation between the immune
antibody level and the challenge protection of the two animals. A basis is provided for the relevance of an efficacy evaluation method in target animal and alternative animal
antibody level and challenge protection, the cost of porcine pseudorabies gE
gene deletion inactivated vaccine development can be effectively reduced, and the problem that porcine pseudorabies virus negative pigs are very difficult to screen at present can be solved.